Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2003
04/08/2003US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa
04/08/2003US6545008 Pyrimidine derivatives and processes for the preparation thereof
04/08/2003US6545006 Process for obtaining L-dihydroorotic acid and use thereof
04/08/2003US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/08/2003US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
04/08/2003US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/08/2003US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation
04/08/2003US6544602 Supertwist liquid-crystal displays and liquid-crystal mixtures therefor
04/08/2003US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care
04/08/2003CA2049630C Cyclic carbonyl containing polymers
04/04/2003WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/04/2003CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/03/2003WO2003027234A2 Small organic molecule regulators of cell proliferation
04/03/2003WO2003027110A2 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones
04/03/2003WO2003027080A1 3-substituted-4-pyrimidone derivatives
04/03/2003WO2003027079A1 Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymers of cycloolefins and hydrogenation products thereof by using the complexes as catalyst
04/03/2003WO2003026667A1 Quinazolino- and quinolino- guanidines as ligands for the neurop eptide ff (npff) receptors
04/03/2003WO2003026661A1 Insulin secretion accelerator and novel pyrimidine derivative
04/03/2003WO2003026570A2 Reduced toxicity cisplatin formulations and methods for using the same
04/03/2003WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis
04/03/2003US20030064980 Respiratory system disorders; antiinflammatory agents
04/03/2003US20030064977 Viricides
04/03/2003US20030064332 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
04/03/2003US20030064173 Having electrically switchable transparency essentially independent of the polarization of incident light
04/03/2003US20030061667 Bis(2,4-diaminophenoxy)pyridines and pyrimidines
04/03/2003CA2461709A1 Small organic molecule regulators of cell proliferation
04/03/2003CA2461219A1 Reduced toxicity cisplatin formulations and methods for using the same
04/03/2003CA2424057A1 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
04/02/2003EP1296995A2 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
04/02/2003EP1296973A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases
04/02/2003EP1296959A1 Methods and compositions utilizing quinazolinones
04/02/2003EP1296958A1 Iminopyrimidine nmda nr2b receptor antagonists
04/02/2003EP1296957A2 Synthesis of chlorinated pyrimidines
04/02/2003EP1296716A2 New formulation
04/02/2003EP1196393B1 Method for producing 4,6-dichloropyrimidine
04/02/2003EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents
04/02/2003EP0862560B1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
04/02/2003EP0759908B1 Substituted diazacyclohexandi(thi)ones
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1407973A Butyne diol derivatives
04/02/2003CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines
04/02/2003CN1406934A Preparation of 4,6-dihydric pyrimidine
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
04/01/2003US6541481 Substituted bicyclic derivatives useful as anticancer agents
04/01/2003US6541129 Organic electroluminescence device and phenylenediamine derivative
04/01/2003CA2288439C Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
04/01/2003CA2217463C Use of sulbutiamine to obtain pharmaceutical compositions which are useful in the treatment of some psychomotor and psychointellectual disorders
03/2003
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024441A1 Novel use of tricyclic compound
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
03/27/2003WO2002042262A3 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
03/27/2003WO2002014286A9 Preparation of risperidone
03/27/2003US20030060628 Process for preparing 4,6-dihydroxypyrimidine (DHP)
03/27/2003US20030060626 Fungicides
03/27/2003US20030060472 Inhibitor of the enzyme catechol-O-methyl transferase (COMT)
03/27/2003US20030060470 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparation comprising them
03/27/2003US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295868A1 Amide compounds and use thereof
03/26/2003EP1295514A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003CN1406232A Method for the simplified production of (3-chloro-4-fluoro-phenyl)-[7- (3-morpholino-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluoro-phenyl)-[7-(3-morpholino-4-yl-propoxy)-6-amino
03/26/2003CN1406231A Pyrimidine compounds
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406229A Pyrimidine compounds
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103764C Substituted phenyl uracils
03/26/2003CN1103763C Process for preparation of substituted pyrimidines
03/25/2003US6538150 Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
03/25/2003US6538143 Reaction product of vinyl ethylene carbonate, methacryloxypropylene carbonate, and allyloxypropylene carbonate; and alkyl or cyclic urea
03/25/2003US6537996 Substituted pyridine or pyrimidine derivatives
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537948 Uracil compounds and use thereof
03/20/2003WO2003022822A1 Aralkylaminopyrimidine, process for producing the same and agricultural/horticultural pesticides
03/20/2003WO2003022820A1 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
03/20/2003WO2003022799A1 Ccr-3 receptor antagonists v
03/20/2003WO2003022790A2 Biphenylene compounds
03/20/2003WO2002102769A3 Methods for synthesizing substituted pyrimidines
03/20/2003WO2002100836A8 Compounds, compositions and methods for modulating beta-amyloid production
03/20/2003WO2002048100A3 Thiosulphonic s-esters as material protective agent
03/20/2003US20030055263 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production